Financings in Brief: Cell Robotics International
This article was originally published in The Gray Sheet
Cell Robotics International: Files registration statement with the Securities and Exchange Commission for an offering of 400,000 units at $20 each -- each unit consisting of a share of convertible preferred stock and two $5 warrants. Proceeds of the offering are tabbed for "manufacturing, marketing, selling and distributing" new medical laser products, including the firm's recently cleared Lasette laser finger perforator device for capillary blood sampling. Paulson Investment Company is lead underwriter for the offering...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.